Your browser doesn't support javascript.
loading
A phase 1 study of NY-ESO-1 vaccine + anti-CTLA4 antibody Ipilimumab (IPI) in patients with unresectable or metastatic melanoma.
Slingluff, Craig L; Zarour, Hassane M; Tawbi, Hussein Abdul-Hassan; Kirkwood, John M; Postow, Michael A; Friedlander, Philip; Devoe, Craig E; Gaughan, Elizabeth M; Mauldin, Ileana S; Olson, Walter C; Smith, Kelly T; Macri, Mary J; Ricciardi, Toni; Ryan, Aileen; Venhaus, Ralph; Wolchok, Jedd D.
Afiliação
  • Slingluff CL; Department of Surgery/Division of Surgical Oncology, University of Virginia, Charlottesville, VA, USA.
  • Zarour HM; Division of Medical Oncology, Dept of Medicine and Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
  • Tawbi HA; Division of Medical Oncology, Dept of Medicine and Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
  • Kirkwood JM; Department of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, TX.
  • Postow MA; Division of Medical Oncology, Dept of Medicine and Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
  • Friedlander P; Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, NY, USA.
  • Devoe CE; Department of Medicine, Hematology, and Medical Oncology, Mount Sinai Medical Center, New York, NY, USA.
  • Gaughan EM; Northwell Health Cancer Institute, Lake Success, NY, USA.
  • Mauldin IS; Department of Medicine/Division of Hematology Oncology, University of Virginia, Charlottesville, VA, USA.
  • Olson WC; Department of Surgery/Division of Surgical Oncology, University of Virginia, Charlottesville, VA, USA.
  • Smith KT; Department of Surgery/Division of Surgical Oncology, University of Virginia, Charlottesville, VA, USA.
  • Macri MJ; Department of Surgery/Division of Surgical Oncology, University of Virginia, Charlottesville, VA, USA.
  • Ricciardi T; Ludwig Institute for Cancer Research, New York, NY, USA.
  • Ryan A; Ludwig Institute for Cancer Research, New York, NY, USA.
  • Venhaus R; Ludwig Institute for Cancer Research, New York, NY, USA.
  • Wolchok JD; Ludwig Institute for Cancer Research, New York, NY, USA.
Oncoimmunology ; 10(1): 1898105, 2021 03 26.
Article em En | MEDLINE | ID: mdl-33796406

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Anticâncer / Melanoma Limite: Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Anticâncer / Melanoma Limite: Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article